Results
126
Companies which are more than 50% undervalued based on analyst price target.
126 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
TEP | €90.90 | 4.8% | -37.6% | €5.4b | €142.53 | PE8.6x | E11.7% | 4.2% | Commercial Services | ||
IPS New | €45.38 | -2.7% | -25.4% | €2.0b | €68.16 | PE10.8x | E9.4% | 3.6% | Media | ||
PEUG | €71.60 | -0.1% | -28.4% | €1.8b | €115.00 | PE15.8x | E15.8% | 4.5% | Diversified Financials | ||
ERA | €53.85 | -5.2% | -16.1% | €1.5b | €85.80 | PS0.5x | E73.7% | 2.8% | Materials | ||
EMEIS | €5.87 | 4.6% | -57.5% | €995.5m | €10.53 | PE0.6x | E-91.2% | 0% | Healthcare | ||
ETL | €1.81 | -11.1% | -46.5% | €929.4m | €2.79 | PS0.7x | E63.6% | 0% | Media | ||
VLTSA | €6.77 | -1.5% | -14.9% | €883.9m | €12.29 | PE26.6x | E9.2% | n/a | Utilities | ||
BASS New | €41.00 | 0.5% | -11.3% | €683.7m | €62.50 | PE13.2x | E30.6% | 3.7% | Real Estate Management and Development | ||
CEN New | €58.20 | -1.4% | -21.8% | €613.3m | €87.67 | PE8.9x | E15.7% | 1.7% | Commercial Services | ||
EQS | €37.15 | -0.7% | -30.3% | €558.4m | €61.33 | PE13.2x | E11.4% | 3.4% | Healthcare | ||
MRN New | €19.38 | -0.5% | -42.7% | €473.5m | €29.64 | PE6.2x | E8.3% | 6.4% | Capital Goods | ||
CO | €0.98 | -8.5% | -98.4% | €417.2m | €2.08 | PE0.2x | E-81.0% | 0% | Consumer Retailing | ||
VLA | €2.36 | 9.3% | -37.8% | €383.5m | €6.84 | PS2.4x | E3.7% | n/a | Pharmaceuticals & Biotech | ||
ABVX | €5.87 | -5.3% | -51.4% | €376.3m | €29.34 | PS41.2x | E18.7% | n/a | Pharmaceuticals & Biotech | ||
WAGA | €15.20 | -2.1% | -36.5% | €375.3m | €27.75 | PS8.3x | E-7.2% | n/a | Energy | ||
AKW | €7.88 | -0.5% | -50.6% | €209.2m | €12.40 | PE6.2x | E-4.2% | 3.8% | Automobiles | ||
IVA | €2.16 | 2.9% | -39.0% | €208.5m | €7.02 | PS10.7x | E31.6% | n/a | Pharmaceuticals & Biotech | ||
PARP | €19.10 | -3.5% | -13.2% | €183.6m | €30.80 | PE25.1x | n/a | 1.7% | Consumer Services | ||
ALSEN | €0.61 | -8.9% | 17.2% | €183.2m | €2.50 | PS29.9x | E-31.5% | n/a | Pharmaceuticals & Biotech | ||
GNFT | €3.53 | 3.5% | -4.1% | €172.3m | €9.45 | PE7.9x | E45.2% | n/a | Pharmaceuticals & Biotech | ||
ALFPC | €100.00 | -2.0% | -11.5% | €166.0m | €174.50 | PE4.9x | E-30.6% | 2.2% | Consumer Durables | ||
ALPUL | €20.35 | 0.2% | 46.4% | €165.5m | €30.78 | PE12.2x | E-22.2% | 0% | Media | ||
NANO | €3.43 | 9.0% | -53.5% | €160.1m | €11.40 | PS3.9x | E31.5% | n/a | Pharmaceuticals & Biotech | ||
DEEZR | €1.35 | 16.9% | -35.9% | €157.5m | €2.03 | PS0.3x | E32.8% | n/a | Media |